Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Yang_Kexin_1000x714_ENV

Kexin Yang

Associate

Shanghai +86 21 6036 2697

  • About
  • Representative Matters
  • Credentials
  • About

    Kexin Yang focuses on government and internal investigations, as well as regulatory work related to food, drugs, and medical devices in China. She has experience advising multinational companies on highly sensitive investigations in China and other countries in Asia, particularly in the areas of FCPA and export controls. In the regulatory sphere, Kexin advises companies in the food, pharmaceutical, biotechnology, medical device, and cosmetics sectors, as well as trade associations, on compliance with Chinese regulations. She has also supported life sciences transactions by evaluating regulatory and compliance risks and advising on commercial agreements.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Conducted internal investigations for several multinational pharmaceutical companies regarding potentially improper interactions with healthcare professionals and expense fraud.
    • Conducted internal investigations for a global electronics equipment and software company into allegations of expense fraud, quid pro quo, embezzlement, and improper entertainment of government officials in Asia.
    • Conducted internal investigations for a multinational beverage company into alleged fraud and embezzlement of distributors and senior management members.
    • Conducted internal investigations for a multinational technology company into allegations of hiring connected third parties, embezzlement, and bid-rigging.
    • Conducted investigations for a multinational advertising company into allegations of alleged fraud and tax issues in its China subsidiary after it was contacted by local enforcement authorities.
    • Conducted internal investigations on behalf of several global technology companies into allegations of potential restricted sales to sanctioned entities, embezzlement, and other violations of U.S. export control laws and regulations.
    • Assisted with discovery and evidence collection for a global technology company in response to a subpoena from a U.S. enforcement authority.
    • Advised multinational pharmaceutical companies on clinical trials involving Chinese human genetic resources, biological data and sample exportation compliance, as well as related government inspections and enforcements.

    • Advised a global medical device company in dealing with an overseas inspection conducted by the NMPA.
    • Advised global beverage and cosmetics companies on their China-related advertisements, labeling, ingredients, and consumer complaint issues.
    • Assisted business associations in drafting and submitting comments on draft legislation and regulations to Chinese regulatory authorities, including the NMPA.
    • Advised multinational pharmaceutical and medical device companies on their operations in China and interactions with government authorities, including regulatory approval pathways, pricing and reimbursement policies, promotional activities, and adverse reaction handling.
    • Conducted regulatory and compliance due diligence, including anti-corruption and anti-bribery due diligence, for patent licensing and transactional matters, and reviewed related commercial agreements.

    Areas of Expertise

  • Credentials
    Education
    • Harvard Law School, LL.M., 2023
        • Harvard Journal of Law and Technology (Submissions Committee)
        • Harvard International Law Journal (Submissions Editor)
    • East China University of Political Science and Law, LL.M., 2019
        • Highest Honor
    • East China University of Political Science and Law, LL.B., 2016
    Bar Admissions
    • PRC Bar Qualification
    • New York
    Languages
    • Mandarin
    • English
    Pro Bono
    • Assisted Acid Survivors Trust International (ASTi), a UK-registered charity, in creating a comparative analysis of corporate obligations and considerations for the supply of acids, aimed at mitigating acid violence and promoting human safety.

    Areas of Expertise

News and Insights

Events